Nutrition, Overgrowth, and Vaccine Efficacy in Low-income Settings

NCT02745327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2019-05-15

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of small intestine bacterial overgrowth (SIBO) on childhood nutritional status, growth, and oral vaccine efficacy.

Conditions

  • Small Intestine Bacterial Overgrowth

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER
  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER
  • University of Virginia

    lead OTHER

Principal Investigators

  • William A Petri, M.D., PhD · University of Virginia

Eligibility

Min Age
1 Day
Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745327 on ClinicalTrials.gov